Industry Satellite Symposia

 

PROMISS & MaNuEL Symposium
Saturday 31 August, 10:00-11:30 Room: THEATRE HALL
Optimal protein intake and malnutrition in older adults – a PROMISS/MaNuEL symposium

Moderators: TBC
Malnutrition risk in European older adults, a Systematic Review with focus on setting, country, and malnutrition screening tool (MaNuEL)

S. Leij (TBC)
Do protein needs differ between older men and women? Sex differences in associations of protein intake with muscle mass and physical functioning (PROMISS)

L. Elstgeest (NL)
Associations of protein intake with muscle parameters in community-dwelling older adults: potential differences by body composition (PROMISS)

L. Hengeveld (NL)
Increasing protein intake among community-dwelling older adults with a lower daily protein intake: results of a feasibility study and design of the PROMISS trial

M. Visser (NL)
 

Abbott Nutrition Health Institute (ANHI)
Saturday 31 August, 12:00-13:30 Room Auditorium HAll
For over 125 years, Abbott has been committed to helping people live their best possible life through the power of health. Abbott’s broad portfolio of science-based nutrition products nourish at every stage of life. Our research is focused on specific health areas, such as the prevention and management of muscle mass loss through specialized nutrition. The Abbott Nutrition Health Institute (ANHI) connects and empowers people through science-based nutrition resources to optimize health worldwide. ANHI presents the latest science by partnering with leading nutrition experts to provide education you can trust. Web: www.anhi.org / www.abbott.com Improving patient outcomes: New insights and evidence on the importance of muscle and targeted nutrition

Moderator: C. Glencorse (UK)
12:00-12:10 Welcome and Introduction

C. Glencorse (UK)
12:10-12:30 Measuring muscle strength and function in clinical practice: Utilising recent guidelines

F. Landi (IT)
12:30-12:50 Why measure muscle mass: Insights into new clinical evidence and measurement tools

C. Prado (CA)
12:50-13:10 Nutrition beyond protein: New strategies to improve muscle outcomes

N. Deutz (USA)
13:10-13:30 Speaker Panel / Q & A / Concluding Remarks
 

BAXTER
Saturday 31 AUGUST, 12:00-13:30 Room THEATRE HALL
 

Web: www.baxter.com - Baxter continues to assist clinicians in treating patients' diverse nutrient needs since the 1940s, when the company first introduced liquid proteins. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. For example, Baxter pioneered the world's first "triple-chamber system" internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN. Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories.

 Power Play: Measuring Energy and Prioritizing Protein in Critically Ill Patients
Indirect Calorimetry

C. Pichard (CH)
Indirect Calorimetry

P. Singer (IL)
Protein

E. De Waele (BE)
BD (Becton, Dickinson and Company)
Sunday 1 September, 12:30-13:30 Room ConF HALL COMPLEX S4_7+8+9+10+11
 Web: www.bd.com BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com Home Parenteral Nutrition – the stakeholders’ perspective into how to best equip patients for a better quality of life

Moderator: S. Garcia (ES)
13:30-12:40 Welcome and Introduction

S. Garcia (ES)
12:40-13:00 The role of mobile pumps in home parenteral nutrition

J. Sobocki (PL)
13:00-13:20 Bitter-sweet taste of life – the patient’s perspective on parenteral nutrition at home

M. Lichota (PL)
13:20-13:30 Q&A and Concluding Remarks

S. Garcia (ES)
 

NESTLE
Sunday 1 September, 18:00-19:30 Room THEATRE HALL
 Nestlé Health Science (NHSc), a wholly-owned subsidiary of Nestlé, is a globally recognized leader in the field of nutritional science. At NHSc we are committed to empowering healthier lives through nutrition for consumers, patients and their healthcare partners. We offer an extensive consumer health portfolio of industry-leading medical nutrition, consumer and VMS brands that are science-based solutions covering all facets of health from prevention, to maintenance, all the way through to treatment. NHSc is redefining the way we approach the management of health in several key areas such as pediatric health, allergy, acute care, oncology, metabolic health, healthy aging, gastrointestinal health, and inborn errors of metabolism. Headquartered in Switzerland, NHSc employs over 5’000 people around the world, who are committed to making a difference in people’s lives, for a healthier today and tomorrow. Web: www.nestlehealthscience.com Undernutrition, Sarcopenia and Frailty: optimizing nutrition care in the elderly

Moderator: S. Klek (PL)
18:00-18:05 Welcome

M. Perugini (TBC)
18:05-18:10 Introduction

S. Klek (PL)
18:10-18:30 Age-associated cellular decline

M. Cesari (IT)
18:30-18:50 Undernutrition, Sarcopenia and Frailty. Is there a link?

P. Abizanda (ES)
18:50-19:10 Oral nutritional support in medical inpatients – is it worth

the EFFORT?

P. Schütz (CH)
19:10-19:25 Debate

S. Klek (PL)
 

 
 

NUTRICIA
Sunday 1 September, 18:00-19:30 Room AUDITORIUM HALL
 Email: medicalnutrition@nutricia.com Tel : +31204569000 Web: www.nutricia.com Nutricia Advanced Medical Nutrition is a specialised business of Danone, focused on pioneering nutritional solutions that help people live healthier and longer lives. Nutricia aims to establish medical nutrition as an integral part of healthcare, to fulfil Danone’s mission to bring health through food to as many people as possible. Nutricia’s extensive range of evidence-based nutrition products and services offer proven benefits and better patient outcomes. The company works with doctors and healthcare professionals in 40 countries to deliver better care and lower healthcare costs, serving patients in hospitals, care homes and in the community. Medical Nutrition at a crossroads : how  to ensure a successful continuum of care. Intervention and implementation along the oncology patient journey

Moderator: E. De Waele (BE)
18:00-18:05 Welcome and Introduction

E. De Waele (BE)
18:05-18:25 Why Medical Nutrition at a crossroads?

A. Laviano (IT)
18:25-18:45 A Personalized Approach to Nutrition Assessment and Intervention: what, when, why.

C. Prado (CA)
18:45-19:05 How to better integrate and implement nutrition in supportive care in hospital settings: challenges & opportunities

C. van de Velde (NL)
19:05-19:25 Patient perspectives of nutrition in cancer care: how to bridge the gaps?

N. Rice (IR)
19:25-19:30 Concluding remarks and Q&A
 

InBody
Monday 2 September, 12:30-13:30 Room Q-HOtel (MOCCA+LATTE)
Email: sykim@inbody.com/global - InBody is a body composition analyzer manufacturing company based in Korea and it has been in the industry for over 20 years. During the past 20 years InBody has developed a solid foundation to create a reputation as the leaders for its precise technology, customer education, and customer service which parallels to the company's core value "Education, Motivation, Application, and Innovation". InBody have been chosen by many noticeable references such as hospitals, sports clubs, global corporates, government affiliates, resorts and etc. InBody is dedicated to inspiring and leading people to live a healthier life. Monitorin Critcally Ill Patients with BIA

Moderators: (TBC)
12:30-12:35 Symposia Introduction

I. Białokoz-Kalinowska (PL)
12:35-12:50 Is BIA Reliable on Practical Use?

L.Cha (KR)
12:50-13:25 Using BIA in ICU: Studies of Critically Ill Patients

J.-M. Lee (KR)
13:25-13:30 Discussion

I. Białokoz-Kalinowska (PL)
 
 

B. Braun Melsengen
Monday 2 September, 16:00-17:30 Room Chamber Hall
With over 60,000 employees in 64 countries, B. Braun is one of the world’s leading manufacturers of medical devices and pharmaceutical products and services. Through constructive dialog, B. Braun develops high quality product systems and services that are both evolving and progressive - and in turn improves people’s health around the world. Email: info@bbraun.com - Tel: +495661710 - Web: www.bbraun.com Nutritional Approach in Cancer – What’s New?

Moderator: S. Klek (PL)
16:00-16:10 Welcome and Introduction

S. Klek (PL)
16:10-16:30 Challenges of nutritional therapy in cancer patients

A. Kapala (PL)
16:30-16:50 Targeted medical Nutrition for cachexia in non-small-cell lung cancer

M. Muscaritoli (IT)
16:50-17:10 Importance of perioperative nutrition in surgical cancer patients

A. Weimann (DE)
17:10-17:30 Discussion
 

Fresenius Kabi
Monday 2 September, 16:00-17:30 Room Auditoritum hall
 

Email: communication@fresenius-kabi.com Tel: +4961726860 Web: www.fresenius-kabi.com Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Products: I.V. generic drugs, infusion therapies, clinical nutrition products and medical devices for administering these products. Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems. The company also develops biosimilars with a focus on oncology and autoimmune diseases.

 Controversies and Evolving Concepts in Critical Care Nutrition

Moderator: P. Singer (IL)
16:00-16:05 Welcome and Introduction

P. Singer (IL)
16:05-16:40 Metabolic Impact of Protein in the Early Phase

Z. Putchcheary (UK)
16:40-17:15 The Clinical Value of Omega-3 Fatty Acids

M. Berger (CH)
17:15-17:25 Concluding Remarks
17:25-17:30 Research Network – JUMPstart Grant

M. Berger (CH)